Science, Discovery, Tech and Environment · 18 November 2026
India's First Indigenous H5N1 Chicken Vaccine Against Clade 2.3.2.1a to Be Dedicated to the Nation on November 20
Exam-focused facts from the 18 November 2026 current affairs briefing.
Key facts
- India has developed its first indigenous inactivated H5N1 vaccine for chickens against the Highly Pathogenic Avian Influenza Clade 2.3.2.1a strain, developed by the ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD), Bhopal.
- Union Agriculture and Farmers Welfare Minister Shivraj Singh Chouhan will dedicate the vaccine to the nation on November 20, 2026, at ICAR-NIHSAD, Bhopal, Madhya Pradesh, per a Ministry of Agriculture and Farmers Welfare announcement issued on November 18, 2026.
- The vaccine is intended for poultry, not humans, and was developed because no specific commercial vaccine was previously available against the H5N1 Clade 2.3.2.1a strain.
- Bird flu was first detected in India in 2006, and more than 500 combined outbreaks of H5N1 and H5N8 subtypes have since been reported, according to the Ministry of Agriculture and Farmers Welfare.
- H5N1 outbreaks can cause nearly 100 percent mortality among infected birds; the government estimates a major bird flu outbreak could reduce India's GDP growth by up to 1.5 percent and put over 20 percent of the poultry population at risk.
- The 2006 bird flu outbreak caused estimated direct and indirect losses of Rs 2,200-3,000 crore, while an outbreak in Manipur caused losses equal to 0.5 percent of that state's GDP.
- According to the WHO, 1,003 human H5N1 cases, including 479 deaths, have been reported across 25 countries, including India, since 2003; Clade 2.3.2.1a infections have also recently been detected in mammals and three human cases.
- Commercial availability and nationwide vaccination arrangements for the new vaccine have not yet been announced.